Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
1030B | Carisoprodol and Metabolite, Blood |
1030FL | Carisoprodol and Metabolite, Fluid |
1030SP | Carisoprodol and Metabolite, Serum/Plasma |
1030U | Carisoprodol and Metabolite, Urine |
1255B | Chlorzoxazone, Blood |
1255SP | Chlorzoxazone, Serum/Plasma |
1287B | Clozapine and Metabolite, Blood |
1287FL | Clozapine and Metabolite, Fluid |
1287SP | Clozapine and Metabolite, Serum/Plasma |
1287TI | Clozapine and Metabolite, Tissue |
1287U | Clozapine and Metabolite, Urine |
1405B | Cyclobenzaprine, Blood |
1405FL | Cyclobenzaprine, Fluid |
1405SP | Cyclobenzaprine, Serum/Plasma |
1405TI | Cyclobenzaprine, Tissue |
1405U | Cyclobenzaprine, Urine |
9129B | Carisoprodol and Metabolite Screen, Blood |
9129FL | Carisoprodol and Metabolite Screen, Fluid |
9129SP | Carisoprodol and Metabolite Screen, Serum/Plasma |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |